| Dr Joanna S Kusmirek, MD | |
|
612 Fayette St, 2nd Floor, Conshohocken, PA 19428-1797 | |
| (610) 828-8500 | |
| (610) 828-9736 |
| Full Name | Dr Joanna S Kusmirek |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 32 Years |
| Location | 612 Fayette St, Conshohocken, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1881740850 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD432562 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Einstein Medical Center Montgomery | East norriton, PA | Hospital |
| Hospital Of Univ Of Pennsylvania | Philadelphia, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Fornance Physician Services Inc | 8527962661 | 105 |
News Archive
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
Taking aspirin after being diagnosed with bowel cancer can reduce the chance of dying from the disease by 30 per cent, new research shows today.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has signed an exclusive collaboration and commercialization agreement with Crucell N.V. for Crucell's rabies monoclonal antibodies (MAbs), next-generation rabies biologicals to be used in association with rabies vaccine for post-exposure prophylaxis against this fatal disease.
Scientists are developing new scaffolding technology which could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures. Their research is highlighted in the latest issue of Business, the quarterly highlights magazine of the Biotechnology and Biological Sciences Research Council (BBSRC).
Eisai Inc. and Arena Pharmaceuticals, Inc. today announced the completion of two Phase 1 registrational clinical trials that Eisai and Arena believe demonstrate bioequivalence of an investigational once-daily extended release formulation of lorcaserin, as compared to the twice-daily immediate release formulation approved by the US Food and Drug Administration and marketed as BELVIQ.
› Verified 4 days ago
| Entity Name | Fornance Physician Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053363523 PECOS PAC ID: 8527962661 Enrollment ID: O20040216000037 |
News Archive
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
Taking aspirin after being diagnosed with bowel cancer can reduce the chance of dying from the disease by 30 per cent, new research shows today.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has signed an exclusive collaboration and commercialization agreement with Crucell N.V. for Crucell's rabies monoclonal antibodies (MAbs), next-generation rabies biologicals to be used in association with rabies vaccine for post-exposure prophylaxis against this fatal disease.
Scientists are developing new scaffolding technology which could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures. Their research is highlighted in the latest issue of Business, the quarterly highlights magazine of the Biotechnology and Biological Sciences Research Council (BBSRC).
Eisai Inc. and Arena Pharmaceuticals, Inc. today announced the completion of two Phase 1 registrational clinical trials that Eisai and Arena believe demonstrate bioequivalence of an investigational once-daily extended release formulation of lorcaserin, as compared to the twice-daily immediate release formulation approved by the US Food and Drug Administration and marketed as BELVIQ.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Joanna S Kusmirek, MD Po Box 789967, Philadelphia, PA 19178-9967 Ph: (484) 622-7395 | Dr Joanna S Kusmirek, MD 612 Fayette St, 2nd Floor, Conshohocken, PA 19428-1797 Ph: (610) 828-8500 |
News Archive
Cognoptix announced today that it has reached the halfway point in a multi-site clinical trial of its SAPPHIRE II eye test designed to identify Alzheimer's disease patients via a beta amyloid ("Ab") signature in their eyes.
Taking aspirin after being diagnosed with bowel cancer can reduce the chance of dying from the disease by 30 per cent, new research shows today.
Sanofi Pasteur, the vaccines division of sanofi-aventis Group, announced today that it has signed an exclusive collaboration and commercialization agreement with Crucell N.V. for Crucell's rabies monoclonal antibodies (MAbs), next-generation rabies biologicals to be used in association with rabies vaccine for post-exposure prophylaxis against this fatal disease.
Scientists are developing new scaffolding technology which could be used to grow tissues such as skin, nerves and cartilage using 3D spaghetti-like structures. Their research is highlighted in the latest issue of Business, the quarterly highlights magazine of the Biotechnology and Biological Sciences Research Council (BBSRC).
Eisai Inc. and Arena Pharmaceuticals, Inc. today announced the completion of two Phase 1 registrational clinical trials that Eisai and Arena believe demonstrate bioequivalence of an investigational once-daily extended release formulation of lorcaserin, as compared to the twice-daily immediate release formulation approved by the US Food and Drug Administration and marketed as BELVIQ.
› Verified 4 days ago
Mrs. Ritamarie Mancini Clarke, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 700 Fayette Street, Conshohocken, PA 19428 Phone: 610-828-0358 Fax: 610-825-9665 | |
Kristie Beth Nichols, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1100 E Hector St, Suite 105, Conshohocken, PA 19428 Phone: 610-828-2608 Fax: 610-828-0102 | |
Dr. Sima Assefi, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1801 Butler Pike, Apt 159, Conshohocken, PA 19428 Phone: 484-532-7480 | |
Harry A Frankel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 E Hector St, Suite 105, Conshohocken, PA 19428 Phone: 610-828-2608 Fax: 610-828-0102 | |
Dr. Glenn Miller Jr., D.O. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 700 Fayette St, Conshohocken, PA 19428 Phone: 610-828-0358 | |
John Lembeck, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 E Hector St, Ste 105, Conshohocken, PA 19428 Phone: 610-828-2608 Fax: 610-828-0102 | |
Kenneth J Varano, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 125 E Elm St Ste 201, Conshohocken, PA 19428 Phone: 215-892-1230 Fax: 610-910-3890 |